Legal & General Group’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.97M | Buy |
35,405
+9,073
| +34% | +$760K | ﹤0.01% | 1802 |
|
|
2025
Q1 | $1.88M | Buy |
26,332
+2,861
| +12% | +$204K | ﹤0.01% | 1948 |
|
|
2024
Q4 | $1.06M | Buy |
23,471
+3,416
| +17% | +$154K | ﹤0.01% | 2220 |
|
|
2024
Q3 | $1.01M | Buy |
20,055
+4,036
| +25% | +$204K | ﹤0.01% | 2231 |
|
|
2024
Q2 | $654K | Buy |
16,019
+3,736
| +30% | +$152K | ﹤0.01% | 2332 |
|
|
2024
Q1 | $526K | Buy |
12,283
+4,556
| +59% | +$195K | ﹤0.01% | 2403 |
|
|
2023
Q4 | $311K | Buy |
+7,727
| New | +$311K | ﹤0.01% | 2616 |
|
|
2021
Q2 | – | Sell |
-445
| Closed | -$8K | – | 3633 |
|
|
2021
Q1 | $8K | Hold |
445
| – | – | ﹤0.01% | 3436 |
|
|
2020
Q4 | $13K | Hold |
445
| – | – | ﹤0.01% | 3253 |
|
|
2020
Q3 | $17K | Buy |
445
+93
| +26% | +$3.55K | ﹤0.01% | 3029 |
|
|
2020
Q2 | $12K | Buy |
+352
| New | +$12K | ﹤0.01% | 3269 |
|